Commercial Application: The invention relates to a process for the large-scale produc-tion of taxanes, in particular Baccatin III and 10-DAB III. These taxanes that occur naturally in the bark of the Pacific or Euro-pean yew tree are, inter alia, precursors of the cytostatic sub-stances Paclitaxel and Docetaxel, which have been used as anticancer drugs under the brand names Taxol® and Taxotere® since the beginning of the 90s. Because of the unique mecha-nism of action, there is a high demand for these substances on the world market. With a turnover of more than 4 billion dollars, taxanes were the best-selling cytostatics worldwide in 2007. Nevertheless, treatments are very expensive because of the market prices for Paclitaxel and Docetaxel or their precursors. There is therefore a requirement for a more effective downstream process for purifying these substances.
Further Information: PDF
Phone: +49 (0)208/94105 10
Dipl.-Ing. Alfred Schillert
email@example.com | TechnologieAllianz e.V.
New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.
Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences